Persistent Calprotectin Elevation After Infection Clearance
Inflammatory Bowel Disease (IBD)
- Persistently elevated calprotectin (>150 mg/g) in asymptomatic patients predicts disease relapse with a 4.4-fold increased risk in ulcerative colitis, according to the American Gastroenterological Association 1, 2
- The infection may have unmasked underlying IBD or triggered post-infectious IBD, as suggested by the American Gastroenterological Association 3, 4
- Calprotectin >150 mg/g warrants endoscopic evaluation to assess for chronic inflammatory conditions, as recommended by the American Gastroenterological Association 4, 5
Clinical Approach
- For persistent calprotectin elevation 10 months post-infection, repeat calprotectin measurement to confirm persistent elevation (not transient), as suggested by the American Gastroenterological Association 4, 5
- If calprotectin >150 mg/g on repeat testing, proceed with endoscopic evaluation to assess for chronic inflammatory conditions, as recommended by the American Gastroenterological Association 4, 5
False Positive Considerations
- False positive rates are substantial: 18-26% in asymptomatic patients depending on cutoff used, according to the American Gastroenterological Association 6, 7
Elevated Calprotectin Levels and Their Clinical Implications
Calprotectin Thresholds and Clinical Decision-Making
- A calprotectin level >150 μg/g indicates active inflammatory disease requiring endoscopic assessment, according to the American Gastroenterological Association 8
- A calprotectin level between 50-150 μg/g requires clinical correlation with symptoms, and repeat measurement in 3-6 months if asymptomatic, or endoscopic evaluation if symptomatic, as recommended by the American Gastroenterological Association 8
- A calprotectin level <50 μg/g essentially rules out significant ongoing inflammation, as stated by the American Gastroenterological Association 9